Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
ImmuCell financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$3.6
2024-10-29
Market Capitalization
$28.1 M
2024-10-29
Revenue
$27.6 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|
| Revenue | 18.6M | 17.5M | 26.5M | 27.6M |
| Cost of goods sold | 10.9M | 13.6M | 18.6M | 16.2M |
| Gross profit | 7.6M | 3.9M | 7.9M | 11.4M |
| Gross profit margin, % | 41.2% | 22.1% | 30.0% | 41.4% |
| General and administrative expense | 2.3M | 2.1M | 2.2M | 3.2M |
| Operating expense total | 9.9M | 9.6M | 9.6M | 9.8M |
| EBIT | (2.3M) | (5.7M) | (1.6M) | 1.6M |
| EBIT margin, % | -12.4% | -32.9% | -6.2% | 6.0% |
| Interest income | 153.1K | 96.6K | 77.7K | |
| Interest expense | 348.5K | 475.6K | 568.7K | |
| Pre tax profit | (2.5M) | (5.8M) | (2.1M) | (1.0M) |
| Income tax expense | 7.7K | 4.6K | 10.1K | 11.6K |
| Net Income | (2.5M) | (5.8M) | (2.2M) | (1.0M) |
| EPS | (0.3) | (0.7) | (0.3) | (0.1) |